Cosmetics Partnerships Leverage the Estée Lauder collaboration to position Serpin Pharma as a provider of anti inflammatory peptide research for skincare, pursuing joint development, licensing, or contract research to create cosmetic actives that enhance skin longevity and inflammation control.

Oncology Pain Alliance The Dogwood Therapeutics SP16 collaboration creates an opportunity to offer peptide therapeutics development, clinical trial support, formulation optimization, and regulatory strategy as CRO or CMO services or co development licenses in cancer related pain.

Neuropathy Funding A 2 million NCI grant demonstrates credibility and potential for neuropathy programs; pursue additional federal grants or academic collaborations and position Serpin as a preferred partner for neuropathy clinical development, allowing milestone based partnerships.

Asia Market Access The HekaBio collaboration provides a pathway to Asian and Australian markets; offer regional regulatory, distribution, and co development opportunities for peptide therapeutics and SP16 after local validation, with potential local manufacturing or partner networks.

Small Team Advantage With a lean team of under ten employees, Serpin Pharma can win by pursuing outsourced development and manufacturing, IP licensing, and strategic advisory deals, offering flexible collaboration models for lead programs to accelerate revenue while minimizing internal headcount.